Traditionally, breast cancer classification is based on immunohistochemical detection of hallmark proteins associated with cell functions, including receptors for Estrogen (ER), Progesterone (PR) and amplification of HER2 (Human Epidermal Growth Factor Receptor 2) [6]. This evidence concerns the gene ERBB2 and breast carcinoma.